FOR PATIENTS · SOURCE READING

Immunotherapy

Source: Prostate Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: December 20, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview / The following types of treatment are used:

Immunotherapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer. Sipuleucel-T is a type of immunotherapy used to treat prostate cancer that has metastasized (spread to other parts of the body).

Source links and citations

Immunotherapy
immune system
Sipuleucel-T
metastasized

For more information, see Drugs Approved for Prostate Cancer.

Source links and citations

Drugs Approved for Prostate Cancer

Preserved source evidence · Independent clinical review pending · Not medical advice